357 related articles for article (PubMed ID: 29336230)
1. Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
Guo Q; Wu D; Yu H; Bao J; Peng S; Shan Z; Guan H; Teng W
Thyroid; 2018 Mar; 28(3):377-385. PubMed ID: 29336230
[TBL] [Abstract][Full Text] [Related]
2. Iodine excess did not affect the global DNA methylation status and DNA methyltransferase expression in T and B lymphocytes from NOD.H-2
Guo Q; Wu D; Fan C; Peng S; Guan H; Shan Z; Teng W
Int Immunopharmacol; 2018 Feb; 55():151-157. PubMed ID: 29253821
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
[TBL] [Abstract][Full Text] [Related]
4. Association of
Hirai N; Watanabe M; Inoue N; Kinoshita R; Ohtani H; Hidaka Y; Iwatani Y
Autoimmunity; 2019; 52(7-8):251-255. PubMed ID: 31552761
[TBL] [Abstract][Full Text] [Related]
5. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
[TBL] [Abstract][Full Text] [Related]
6. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
7. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Bossowski A; Urban M; Stasiak-Barmuta A
J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
[TBL] [Abstract][Full Text] [Related]
8. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications.
Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A
Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265
[TBL] [Abstract][Full Text] [Related]
9. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
10. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
11. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
12. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Bossowski A; Stasiak-Barmuta A; Urban M
Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
[TBL] [Abstract][Full Text] [Related]
13. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
14. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune diseases of the thyroid gland].
Allelein S; Feldkamp J; Schott M
Internist (Berl); 2017 Jan; 58(1):47-58. PubMed ID: 28074218
[TBL] [Abstract][Full Text] [Related]
16. Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism.
Shigemasa C; Shirota K; Urabe K; Kouchi T; Mitani Y; Ueta Y; Yoshida A; Mashiba H
Horm Res; 1991; 35(5):208-12. PubMed ID: 1687041
[TBL] [Abstract][Full Text] [Related]
17. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
18. Production of and response to interleukin-2 in Graves' disease.
Eisenstein Z; Engelsman E; Weiss M; Kalechman Y; Sredni B
J Clin Immunol; 1988 Sep; 8(5):349-55. PubMed ID: 2972741
[TBL] [Abstract][Full Text] [Related]
19. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
20. Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease.
Nakanishi K; Taniguchi Y; Ohta Y
Acta Endocrinol (Copenh); 1991 Sep; 125(3):253-8. PubMed ID: 1683085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
